Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2785325 Title: COMPOSITIONS PHARMACEUTIQUES DE 7-(6-(2-HYDROXYPROPAN-2-Y1)PYRIDIN-3-YL)-1-((TRANS)-4-MÉTHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO[2,3-B]PYRAZIN-2(1H)-ONE, FORME SOLIDE DE CELLES-CI ET LEURS PROCÉDÉS D'UTILISATION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
127985653
WO application number:
US2012067172
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2785325
WO publication number:
WO2013082344
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
30/11/2012
Grant date:
22/08/2018
EP publication date:
08/10/2014
WO publication date:
06/06/2013
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/08/2018
EP B1 publication date:
22/08/2018
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/11/2018
Expiration date (if granted and all annual fees paid):
30/11/2032

Applicant

Name:
Signal Pharmaceuticals, LLC
Legal Form:
From:
22/08/2018
Address:
10300 Campus Point Drive, Suite 100, San Diego, CA 92121, United States (US)
To:

Inventor

1

Name:
CONNOLLY, Terrence, Joseph
Legal Form:
Address:
Warwick, NY 10990, United States (US)

2

Name:
KLOPFER, Kevin, Joseph
Legal Form:
Address:
Flemington, NJ 08822, United States (US)

3

Name:
LEONG, William, Wei-Hwa
Legal Form:
Address:
Westfield, NJ 07090, United States (US)

4

Name:
MENON, Anil
Legal Form:
Address:
Martinsville, NJ 08836, United States (US)

5

Name:
MIKLOS, Amanda, Nicole
Legal Form:
Address:
Hoboken, NJ 07030, United States (US)

6

Name:
KREILEIN, Matthew Michael
Legal Form:
Address:
Watchung, New Jersey 07069, United States (US)

7

Name:
GAMBOA, Juan Antonio
Legal Form:
Address:
New York City, New York 10014, United States (US)

8

Name:
XU, Jean
Legal Form:
Address:
Warren, New Jersey 07059, United States (US)

9

Name:
BOERSEN, Nathan
Legal Form:
Address:
Summit, New Jersey 07901, United States (US)

10

Name:
HUI, Ho-Wah
Legal Form:
Address:
Basking Ridge, New Jersey 07920, United States (US)

11

Name:
LEE, Thomas
Legal Form:
Address:
Ma On Shan, Shatin, N.T. Hong Kong, China (CN)

12

Name:
LI, Ying
Legal Form:
Address:
Millburn, New Jersey 07041, United States (US)

13

Name:
COHEN, Benjamin
Legal Form:
Address:
Cranford, New Jersey 07016, United States (US)

Priority

1

Priority patent number:
201161566109 P
Priority date:
02/12/2011
Priority country:
United States (US)

2

Priority patent number:
201261647288 P
Priority date:
15/05/2012
Priority country:
United States (US)

3

Priority patent number:
201261653439 P
Priority date:
31/05/2012
Priority country:
United States (US)

4

Priority patent number:
201261670419 P
Priority date:
11/07/2012
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/00; A61K 9/20; A61K 9/28; A61K 31/4985; C07D 487/04; A61P 35/00;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2018/23
Publication date:
25/10/2018
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2019/21
Publication date:
19/08/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
201834
Publication date:
22/08/2018
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type